当前位置: X-MOL 学术J Pediatr. Endocrinol. Metab. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Who should return for an oral glucose tolerance test? A proposed clinical pathway based on retrospective analysis of 332 children
Journal of Pediatric Endocrinology and Metabolism ( IF 1.3 ) Pub Date : 2021-07-01 , DOI: 10.1515/jpem-2020-0689
Sarah Wing-Yiu Poon 1 , Wilfred Hing-Sang Wong 1 , Anita Man-Ching Tsang 1 , Grace Wing-Kit Poon 1 , Joanna Yuet-Ling Tung 1, 2
Affiliation  

Objectives Fasting plasma glucose or oral glucose tolerance test (OGTT) is the traditional diagnostic tool for type 2 diabetes (T2DM). However, fasting is required and implementation in all overweight/obese subjects is not practical. This study aimed to formulate a clinical pathway to stratify subjects according to their risk of abnormal OGTT. Methods This retrospective study included patients with overweight or obesity who had undergone OGTT in a tertiary paediatric unit from 2012 to 2018. The optimal haemoglobin A1c (HbA1c) cutoff that predicts abnormal OGTT was evaluated. Other non-fasting parameters, in combination with this HbA1c cutoff, were also explored as predictors of abnormal OGTT. Results Three hundred and thirty-two patients (boys: 54.2%, Chinese: 97.3%) were included for analysis, of which, 272 (81.9%) patients had normal OGTT while 60 (18.0%) patients had abnormal OGTT (prediabetes or T2DM). Optimal HbA1c predicting abnormal OGTT was 5.5% (AUC 0.71; sensitivity of 66.7% and specificity of 71%). When HbA1c≥5.5% was combined with positive family history and abnormal alanine transaminase (ALT) level, the positive predictive value for abnormal OGTT was increased from 33.6 to 61.6%. Conclusions HbA1c, family history of T2DM and ALT level could be used to derive a clinical pathway to stratify children who have high risk of abnormal OGTT.
更新日期:2021-07-07
down
wechat
bug